March 11, 2018
Article
Editor's Page
Never in their wildest dreams dreams would immunologists from the last generation have imagined chimeric antigen receptor (CAR)-T cell therapy coming to light. The very notion of genetically engineering a T cell to recognize a tumor antigen would have been viewed almost as a pipe dream.
March 06, 2018
Article
Features
Nutritional change may be a potential strategy to improve symptom burden and inflammation in patients with MPNs, whohave increased inflammatory cytokines, which contribute to symptoms such as fatigue, night sweats and bone pain, as well as low cholesterol and weight loss related to nutritional deficiencies.
March 05, 2018
Article
Speaking Out
A retired oncologist and survivor talks cancer in a digital world.
March 04, 2018
Article
Features
Survey finds quality of life and cost affect treatment decisions.
March 02, 2018
Article
From the Chairman
FOR THE FIRST TIME in more than 40 years, patients with acute myeloid leukemia (AML) have reason to hope. After years of little to no improvement, four new agents were approved in the same year bringing huge advancements to the field.
March 02, 2018
Article
Features
Experts focus on genetic abnormalities to advance cancer care.
February 24, 2018
Article
Features
Experts examine the use of Adcetris for patients with Hodgkin lymphoma.
February 23, 2018
Article
Features
New drugs bring advancements to acute myeloid leukemia after 40 years.
February 22, 2018
Article
Features
Newly approved CAR-T cell treatments inspire hope in patients with blood cancer.